Showing results (1-10 of 133) with videos related to
Sort By:
Pageof 14
Journal of the National Comprehensive Cancer Network : JNCCN|August 12, 2008
Controversies in the management of oropharynx cancerFrancis P Worden, Huan HaOncotargets and Therapy|April 26, 2016
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitorsAssuntina G Sacco, Francis P WordenThe Oncologist|September 24, 2020
A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell CarcinomaIrene Tsung, Francis P Worden, Robert J FontanaDrugs|April 1, 2017
The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted TherapiesRoy Lirov, Francis P Worden, Mark S CohenCurrent Clinical Pharmacology|May 19, 2016
Axitinib in the Treatment of Head and Neck MalignanciesPaul L Swiecicki, Matthew Spector, Francis P WordenWorld Journal of Clinical Oncology|February 11, 2016
Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approachesPaul L Swiecicki, Kelly M Malloy, Francis P WordenJournal of the Endocrine Society|May 31, 2023
Access Denied: Disparities in Thyroid Cancer Clinical TrialsDebbie W Chen, Francis P Worden, Megan R HaymartImmunotherapy|March 2, 2022
Infrequent liver injury from cemiplimab in patients with advanced cutaneous squamous cell carcinomaLinnea Swanson, Ihab Kassab, Irene Tsung, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2017
Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SELECT TrialMarcia S Brose, Francis P Worden, Kate L Newbold, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 24, 2023
Real-World Use of Systemic Therapies for the Treatment of Advanced Thyroid CancersDebbie W Chen, Mousumi Banerjee, Tianyi Xu, et al.Pageof 14